GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (TSXV:RX) » Definitions » Cyclically Adjusted Book per Share

Biosyent (TSXV:RX) Cyclically Adjusted Book per Share : C$2.02 (As of Mar. 2024)


View and export this data going back to 1979. Start your Free Trial

What is Biosyent Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Biosyent's adjusted book value per share for the three months ended in Mar. 2024 was C$2.974. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$2.02 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Biosyent's average Cyclically Adjusted Book Growth Rate was 17.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 23.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 25.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 34.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Biosyent was 47.40% per year. The lowest was -4.40% per year. And the median was 28.90% per year.

As of today (2024-06-07), Biosyent's current stock price is C$9.18. Biosyent's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was C$2.02. Biosyent's Cyclically Adjusted PB Ratio of today is 4.54.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Biosyent was 98.08. The lowest was 4.16. And the median was 13.19.


Biosyent Cyclically Adjusted Book per Share Historical Data

The historical data trend for Biosyent's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent Cyclically Adjusted Book per Share Chart

Biosyent Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 1.03 1.30 1.64 1.94

Biosyent Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.72 1.80 1.88 1.94 2.02

Competitive Comparison of Biosyent's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Biosyent's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyent's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biosyent's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biosyent's Cyclically Adjusted PB Ratio falls into.



Biosyent Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biosyent's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.974/126.2576*126.2576
=2.974

Current CPI (Mar. 2024) = 126.2576.

Biosyent Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.459 99.473 0.583
201409 0.534 99.394 0.678
201412 0.589 98.367 0.756
201503 0.663 99.789 0.839
201506 0.724 100.500 0.910
201509 0.811 100.421 1.020
201512 0.867 99.947 1.095
201603 0.938 101.054 1.172
201606 1.012 102.002 1.253
201609 1.104 101.765 1.370
201612 1.162 101.449 1.446
201703 1.224 102.634 1.506
201706 1.337 103.029 1.638
201709 1.431 103.345 1.748
201712 1.531 103.345 1.870
201803 1.615 105.004 1.942
201806 1.734 105.557 2.074
201809 1.829 105.636 2.186
201812 1.912 105.399 2.290
201903 1.896 106.979 2.238
201906 1.795 107.690 2.104
201909 1.860 107.611 2.182
201912 1.906 107.769 2.233
202003 1.952 107.927 2.284
202006 1.959 108.401 2.282
202009 2.039 108.164 2.380
202012 2.093 108.559 2.434
202103 2.184 110.298 2.500
202106 2.268 111.720 2.563
202109 2.359 112.905 2.638
202112 2.513 113.774 2.789
202203 2.581 117.646 2.770
202206 2.654 120.806 2.774
202209 2.713 120.648 2.839
202212 2.758 120.964 2.879
202303 2.763 122.702 2.843
202306 2.779 124.203 2.825
202309 2.923 125.230 2.947
202312 2.961 125.072 2.989
202403 2.974 126.258 2.974

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Biosyent  (TSXV:RX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biosyent's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=9.18/2.02
=4.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Biosyent was 98.08. The lowest was 4.16. And the median was 13.19.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Biosyent Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Biosyent's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosyent (TSXV:RX) Business Description

Industry
Traded in Other Exchanges
Address
2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.
Executives
Peter Douglas Lockhard Director

Biosyent (TSXV:RX) Headlines

No Headlines